Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Environ Manage ; 326(Pt A): 116675, 2023 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-36379078

RESUMEN

Coastal zones are usually composed of coastlines and coastal wetlands and are among the most productive and dynamic ecosystems. However, the deltas are seldom detected and compared in detail at the continental scale to investigate the spatiotemporal evolution of coastline migration and coastal wetlands. Here we detected and compared the spatiotemporal changes in coastlines, wetlands, and ecosystem services in major deltas in Asia, including the Yellow River Delta (YRD), Yangtze River Delta (YAD), Pearl River Delta (PRD), Red River Delta (RRD), Mekong River Delta (MERD), Chao Phraya River Delta (CPRD), Mahanadi River Delta (MARD), Krishna River Delta (KRD), and Indus River Delta (IRD). We used time series remote sensing images from 1990 to 2019 to derive coastline and wetland information for the nine coastal zones. The ecosystem service value coefficients were applied to explore the ecosystem services characteristics of wetland changes in coastal areas. We found that the coastlines of the deltas in the study area changed less in the bedrock and sandy coasts, while the coastlines in the silty delta coasts changed more from 1990 to 2019. The interannual dynamics of coastal wetland areas in nine major deltas over the nearly 30 years can be divided into three periods: decreasing variability (1990-2005), increasing variability (2005-2015), and increasing volatility (2015-2019). Ecosystem services had an overall downward trend. These findings complement the official database of coastal planning and have substantial guiding implications for adjusting coastal management regulation policies.


Asunto(s)
Ecosistema , Humedales , Ríos , Asia , China
2.
Artículo en Inglés | MEDLINE | ID: mdl-31118958

RESUMEN

Objective. To evaluate the efficacy and safety of traditional Chinese medicine in preventing kidney damage caused by Henoch-Schonlein Purpura (HSP) in Children by meta-analysis. Methods. We systematically searched the main Chinese and English electronic databases and collected randomized controlled trials of Chinese herbs in children with HSP until July 2018. Then we used the bias risk assessment tool in Cochrane Handbook 5. 1. 0 to complete the risk assessment of the included studies. We utilized STATA12.0 and RevMan 5.3 for meta-analysis and GRADE pro. for quality evaluation of evidence. Result. (1) Meta-analysis: data from 39 studies, representing 3643 individuals, were included in the analysis. Thirty-seven studies were treated with traditional Chinese medicine for clearing away heat and cooling blood, which were combined. On this basis, subgroup analysis was conducted according to the bias risk of the original study. It showed that Chinese herbs can significantly improve the treatment effect (OR: 4.31, 95% CI [3.34, 5.57], P < 0.01) and reduce the risk of renal damage (RR: 0.36; 95% CI [0.21, 0.61], P < 0.01) and the risk of recurrence (RR: 0.43, 95% CI [0.34, 0.54], P<0.01). (2) Side effect: a total of 7 studies described adverse reactions, and 12 of 319 patients in therapy group had adverse events and 20 of 263 patients in control group. (3) Publication bias: the bias risk Egger's test for the incidence of kidney injury was P=0.572, the relapse rate Egger's test was P=0.175, the efficiency was combined with the low-risk original study, and the bias risk Egger's test was P=0.175. There was not any significant publication bias based on the funnel plot and Egger's test. (4) GRADE evaluation: GRADE evaluation showed that the quality of evidence in the risk of renal damage and recurrence rate was moderate. Conclusion. Chinese medicine treatment can prevent the occurrence of renal damage in children with HSP and can reduce the recurrence rate, the incidence of adverse reactions, and the effect in terms of efficiency. However, the quality of the included studies in the meta-analysis and the quality of the evidence of outcomes were not high; the clinical use of the evidence needs to be cautious.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA